Navigation Links
Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
Date:12/17/2008

A Complimentary Continuing Medical Education Newsletter Series for Physicians

VOORHEES, N.J., Dec. 17 /PRNewswire/ -- Management of Clostridium difficileinfection (CDI) in geriatric and pediatric populations can be challenging and complicated. Because of the observed increase in CDI incidence in many age groups, healthcare professionals need to be especially attuned to the individual needs of these patient populations.

To address the need for current education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing medical education (CME) newsletter series entitled Current Concepts in Clostridium difficile Infection. The third issue of this three-part newsletter series has just been released and is entitled Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients. The newsletter series is supported by an educational grant from ViroPharma Incorporated.

Expert faculty for this CME activity include Ciaran P. Kelly, MD, Associate Professor of Medicine at Harvard Medical School, and Director of Gastroenterology Fellowship Training and Chief, Herman L. Blumgart Internal Medicine Firm at Beth Israel Deaconess Medical Center in Boston, Massachusetts; and Vivian G. Loo, MD, MSc, FRCPC, Associate Professor of Medicine at McGill University and Chief of the Department of Microbiology at McGill University Health Centre in Montreal, Quebec, Canada.

Physicians can download or order online each of the three newsletters in the Current Concepts in Clostridium difficile Infection series: A Focus on Recurrent Disease, A Focus on Severe Disease, and A Focus on Geriatric and Pediatric Patients by visiting www.rmei.com/CDInewsletters.

"Quality continuing medical education is vital to developing and increasing knowledge and skills and enhancing patient care," says RMEI President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CRSTI and Medical City Hospital Dallas Currently Recruiting For a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure
2. CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb
3. Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers
4. Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect
5. MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
6. The CoverMe Foundation Responds to Current U.S. Economic Crisis Offering Healthcare Coverage Solutions to Uninsured
7. Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest
8. Survey finds widespread dissatisfaction with current health care payment system
9. New topical approach to treating nail fungus circumvents problems with current therapy
10. Response Biomedical Announces Insider Participation in Current Financing
11. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: